Fig. 5From: Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusionAssociation between positive TFAP2D immunostaining and androgen receptor (AR) status in all cancers, ERG negative and ERG positive cancersBack to article page